Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: A Partially Blinded Randomized Clinical Trial to Study the Immunogenicity and Safety of Intradermal Administration of ZOSTAVAX™ (V211)
Brief Summary: This study will compare the safety and immunogenicity of ZOSTAVAX™ (V211) administered both intradermally and subcutaneously at various doses.


Options:
A: Arm Label: GSK1437173A Group; Type: EXPERIMENTAL; Interventions: Biological: Herpes Zoster vaccine GSK 1437173A, Biological: Boostrix | Arm Label: Control Group; Type: ACTIVE_COMPARATOR; Interventions: Biological: Herpes Zoster vaccine GSK 1437173A, Biological: Boostrix | Intervention Type: BIOLOGICAL; Name: Herpes Zoster vaccine GSK 1437173A; Assigned to Arm(s): Control Group, GSK1437173A Group | Intervention Type: BIOLOGICAL; Name: Boostrix; Assigned to Arm(s): Control Group, GSK1437173A Group
B: Arm Label: Arm 1; Type: EXPERIMENTAL; Interventions: Biological: Varicella-zoster vaccine | Arm Label: Arm 2; Type: PLACEBO_COMPARATOR; Interventions: Biological: Placebo | Intervention Type: BIOLOGICAL; Name: Varicella-zoster vaccine; Assigned to Arm(s): Arm 1 | Intervention Type: BIOLOGICAL; Name: Placebo; Assigned to Arm(s): Arm 2
C: Arm Label: GSK1437173A Group; Type: EXPERIMENTAL; Interventions: Biological: GSK Biologicals Herpes Zoster subunit (HZ/su) vaccine (GSK 1437173A) | Arm Label: Control Group; Type: ACTIVE_COMPARATOR; Interventions: Biological: GSK Biologicals Herpes Zoster subunit (HZ/su) vaccine (GSK 1437173A) | Intervention Type: BIOLOGICAL; Name: GSK Biologicals Herpes Zoster subunit (HZ/su) vaccine (GSK 1437173A); Assigned to Arm(s): Control Group, GSK1437173A Group
D: Arm Label: Full Dose Subcutaneous; Type: ACTIVE_COMPARATOR; Interventions: Biological: ZOSTAVAX™ (Zoster Vaccine Live) Full Dose Subcutaneous, Biological: Intradermal Placebo | Arm Label: 1/3 Dose Subcutaneous; Type: EXPERIMENTAL; Interventions: Biological: ZOSTAVAX™ (Zoster Vaccine Live) 1/3 Dose Subcutaneous, Biological: Intradermal Placebo | Arm Label: Full Dose Intradermal; Type: EXPERIMENTAL; Interventions: Biological: ZOSTAVAX™ (Zoster Vaccine Live) Full Dose Intradermal, Biological: Full Dose Intradermal Placebo | Arm Label: 1/3 Dose Intradermal; Type: EXPERIMENTAL; Interventions: Biological: ZOSTAVAX™ (Zoster Vaccine Live) Partial Doses Intradermal, Biological: Intradermal Placebo | Arm Label: 1/10 Dose Intradermal; Type: EXPERIMENTAL; Interventions: Biological: ZOSTAVAX™ (Zoster Vaccine Live) Partial Doses Intradermal, Biological: Intradermal Placebo | Arm Label: 1/27 Dose Intradermal; Type: EXPERIMENTAL; Interventions: Biological: ZOSTAVAX™ (Zoster Vaccine Live) Partial Doses Intradermal, Biological: Intradermal Placebo | Intervention Type: BIOLOGICAL; Name: ZOSTAVAX™ (Zoster Vaccine Live) Full Dose Subcutaneous; Assigned to Arm(s): Full Dose Subcutaneous | Intervention Type: BIOLOGICAL; Name: ZOSTAVAX™ (Zoster Vaccine Live) 1/3 Dose Subcutaneous; Assigned to Arm(s): 1/3 Dose Subcutaneous | Intervention Type: BIOLOGICAL; Name: ZOSTAVAX™ (Zoster Vaccine Live) Full Dose Intradermal; Assigned to Arm(s): Full Dose Intradermal | Intervention Type: BIOLOGICAL; Name: ZOSTAVAX™ (Zoster Vaccine Live) Partial Doses Intradermal; Assigned to Arm(s): 1/10 Dose Intradermal, 1/27 Dose Intradermal, 1/3 Dose Intradermal | Intervention Type: BIOLOGICAL; Name: Full Dose Intradermal Placebo; Assigned to Arm(s): Full Dose Intradermal | Intervention Type: BIOLOGICAL; Name: Intradermal Placebo; Assigned to Arm(s): 1/10 Dose Intradermal, 1/27 Dose Intradermal, 1/3 Dose Intradermal, 1/3 Dose Subcutaneous, Full Dose Subcutaneous

Answer: D